Sobi, Swedish Maker of Drugs for Rare Diseases, Receives Takeover Bid by CHAD BRAY

By CHAD BRAY

Swedish Orphan Biovitrum, which make the ReFacto AF treatment for hemophilia for Pfizer, received a preliminary offer from an undisclosed suitor.

Published: April 28, 2015 at 12:00AM

from NYT Business Day http://ift.tt/1HNv0em

from WordPress http://ift.tt/1EItPfH
via Hadi Aboukhater